Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 4,119 shares at $90.25 ($374K) on 2021-03-02, disclosed to the SEC on 2021-03-03.
Open-market sale of $374k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.44 | 881 | $81K | 21.8% |
| 2 | $90.25 | 1,619 | $146K | 39.1% |
| 3 | $90.25 | 1,619 | $146K | 39.1% |
| Total | $90.72 avg | 4,119 | $374K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |